SBF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.743800E-01
Normal-vs-Stage2
9.589400E-01
Normal-vs-Stage3
1.963170E-01
Normal-vs-Stage4
8.343000E-01
Stage1-vs-Stage2
6.452000E-01
Stage1-vs-Stage3
5.566400E-02
Stage1-vs-Stage4
9.884000E-01
Stage2-vs-Stage3
1.649560E-01
Stage2-vs-Stage4
7.203600E-01
Stage3-vs-Stage4
2.304600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.793400E-01
Normal-vs-AfricanAmerican
8.852600E-01
Normal-vs-Asian
7.390800E-01
Caucasian-vs-AfricanAmerican
6.704200E-01
Caucasian-vs-Asian
6.700200E-01
AfricanAmerican-vs-Asian
5.623800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.972600E-01
Normal-vs-Female
9.385200E-01
Male-vs-Female
7.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.577000E-01
Normal-vs-Age(41-60Yrs)
6.972800E-01
Normal-vs-Age(61-80Yrs)
7.498800E-01
Normal-vs-Age(81-100Yrs)
5.429400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.234600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.296400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.584600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.326280E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.111900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.358600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.460800E-01
Normal-vs-Daily Drinker
6.601400E-01
Normal-vs-Weekly Drinker
5.760000E-01
Normal-vs-Occasional Drinker
4.610400E-01
Normal-vs-Social Drinker
5.846800E-01
Non Drinker-vs-Daily Drinker
6.646400E-01
Non Drinker-vs-Weekly Drinker
9.259800E-01
Non Drinker-vs-Occasional Drinker
1.197790E-02
Non Drinker-vs-Social Drinker
1.518320E-02
Daily Drinker-vs-Weekly Drinker
8.077400E-01
Daily Drinker-vs-Occasional Drinker
2.397900E-02
Daily Drinker-vs-Social Drinker
7.950100E-02
Weekly Drinker-vs-Occasional Drinker
3.690000E-02
Weekly Drinker-vs-Social Drinker
7.900200E-02
Occasional Drinker-vs-Social Drinker
5.114400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.235700E-02
Normal-vs-Grade 2
8.380700E-03
Normal-vs-Grade 3
8.882800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.911700E-02
Grade 1-vs-Grade 3
1.180320E-02
Grade 1-vs-Grade 4
8.235700E-02
Grade 2-vs-Grade 3
1.082030E-01
Grade 2-vs-Grade 4
8.380700E-03
Grade 3-vs-Grade 4
8.882800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.622800E-01
Normal-vs-NonDiabetic
9.299000E-01
Diabetic-vs-NonDiabetic
2.639400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.607600E-01
Normal-vs-NoPancreatitis
8.389200E-01
Pancreatitis-vs-NoPancreatitis
6.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.669200E-01
Normal-vs-N1
9.335600E-01
N0-vs-N1
7.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.880000E-01
Normal-vs-TP53-NonMutant
9.252400E-01
TP53-Mutant-vs-TP53-NonMutant
3.912100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
